Norketotifen

DRUG3 trials

Sponsors

Emergo Therapeutics, Inc.

Conditions

Allergic RhinitisAllergic RhinoconjunctivitisInfluenzaInfluenza -Like Illness

Phase 2

Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis

CompletedNCT03887026

Emergo Therapeutics, Inc.Allergic Rhinitis, Allergic Rhinoconjunctivitis

Start: 2019-04-01End: 2019-05-29Updated: 2020-08-21

Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

CompletedNCT04043923

Emergo Therapeutics, Inc.Influenza -Like Illness

Start: 2019-10-21End: 2020-04-20Updated: 2021-03-24

Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness

CompletedNCT04610047

Emergo Therapeutics, Inc.Influenza, Influenza -Like Illness

Start: 2020-12-14End: 2022-02-09Updated: 2023-01-30